Dihydrofolate reductase from Kaposi's sarcoma-associated herpesvirus

Virology

Volumn 268, Issue 1, 2000, Pages 201-217

  Cinquina, Craig C ^a   Grogan, Elizabeth ^a   Sun, Ren ^a   Lin, Su Fang ^a   Beardsley, G Peter ^a   Miller, George ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPTERIN; DIHYDROFOLATE REDUCTASE; DIHYDROFOLATE REDUCTASE INHIBITOR; DIHYDROFOLIC ACID; MESSENGER RNA; METHOTREXATE; PIRITREXIM; PYRIMETHAMINE; RECOMBINANT ENZYME; TRIMETHOPRIM;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; VIRUS REPLICATION;

DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8;

EID: 0034007479     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0165     Document Type: Article

References (61)

1. Albrecht J. C., Nicholas J., Biller D., Cameron K. R., Biesinger B., Newman C., Wittmann S., Craxton M. A., Coleman H., Fleckenstein B., Honess R. W. Primary structure of the herpesvirus saimiri genome. J. Virol. 66:1992;5047-5058.
2. Ambroziak J. A., Blackbourn D. J., Herndier B. G., Glogau R. G., Gullett J. H., McDonald A. R., Lennette E. T., Levy J. A. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science. 268:1995;582-583.
3. Appleman J. R., Beard W. A., Delcamp T. J., Prendergast N. J., Freisheim J. H., Blakley R. L. Atypical transient state kinetics of recombinant human dihydrofolate reductase produced by hysteretic behavior: Comparison with dihydrofolate reductases from other sources. J. Biol. Chem. 264:1989;2625-2633.
4. Appleman J. R., Beard W. A., Delcamp T. J., Prendergast N. J., Freisheim J. H., Blakley R. L. Unusual transient- and steady-state kinetic behavior is predicted by the kinetic scheme operational for recombinant human dihydrofolate reductase. J. Biol. Chem. 265:1990;2740-2748.
5. Appleman J. R., Howell E. E., Kraut J., Kuhl M., Blakley R. L. Role of aspartate 27 in the binding of methotrexate to dihydrofolate reductase from Escherichia coli. J. Biol. Chem. 263:1988a;9187-9198.
6. Appleman J. R., Prendergast N., Delcamp T. J., Freisheim J. H., Blakley R. L. Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase. J. Biol. Chem. 263:1988b;10304-10313.
7. Bernstein H., Bernstein C. Bacteriophage T4 genetic homologies with bacteria and eucaryotes. J. Bacteriol. 171:1989;2265-2270.
8. Bertino J. R., Cashmore A. R., Hillcoat B. L. Induction of dihydrofolate reductase: Purification and properties of the induced human erythrocyte and leukocyte enzyme and normal bone marrow enzyme. Cancer Res. 30:1970;2372-2378.
9. Blakley R. Crystalline dihydropteroylglutamic acid. Nature. 188:1960;231-232.
10. Blakley R. L. Eukaryotic dihydrofolate reductase. Adv. Enzymol. Relat. Areas Mol. Biol. 70:1995;23-102.
11. Blasig C., Zietz C., Haar B., Neipel F., Esser S., Brockmeyer N. H., Tschachler E., Colombini S., Ensoli B., Sturzl M. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 71:1997;7963-7968.
12. Brown K. A., Kraut J. Exploring the molecular mechanism of dihydrofolate reductase. Faraday Discuss. 93:1992;217-224.
13. Brown S. S., Neal G. E., Williams D. C. Subcellular distribution of some folic acid-linked enzymes in rat liver. Biochem. J. 97:1965;34C-36C.
14. Cannon J. S., Hamzeh F., Moore S., Nicholas J., Ambinder R. F. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. J. Virol. 73:1999;4786-4793.
15. Chan S. R., Bloomer C., Chandran B. Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody. Virology. 240:1998;118-126.
16. Chen M. J., Shimada T., Moulton A. D., Cline A., Humphries R. K., Maizel J., Nienhuis A. W. The functional human dihydrofolate reductase gene. J. Biol. Chem. 259:1984;3933-3943.
17. Chen X., Mathews C. K., Wheeler L. J., Maley G., Maley F., Coombs D. H. An immunoblot assay reveals that bacteriophage T4 thymidylate synthase and dihydrofolate reductase are not virion proteins. J. Virol. 69:1995;2119-2125.
18. Coen D. M., Kosz-Vnenchak M., Jacobson J. G., Leib D. A., Bogard C. L., Schaffer P. A., Tyler K. L., Knipe D. M. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. USA. 86:1989;4736-4740.
19. de Bruyn Kops A., Uprichard S. L., Chen M., Knipe D. M. Comparison of the intranuclear distributions of herpes simplex virus proteins involved in various viral functions. Virology. 252:1998;162-178.
20. Desrosiers R. C., Bakker A., Kamine J., Falk L. A., Hunt R. D., King N. W. A region of the Herpesvirus saimiri genome required for oncogenicity. Science. 228:1985;184-187.
21. Desrosiers R. C., Silva D. P., Waldron L. M., Letvin N. L. Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization. J. Virol. 57:1986;701-705.
22. Domin B. A., Grill S. P., Bastow K. F., Cheng Y. C. Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells. Mol. Pharmacol. 21:1982;478-482.
23. Elion G. B. Acyclovir: discovery, mechanism of action, and selectivity. J. Med. Virol. 1:1993;2-6.
24. Ercikan E., Waltham M., Dicker A., Schweitzer B., Bertino J. R. Effect of codon 22 mutations on substrate and inhibitor binding for human dihydrofolate reductase. Adv. Exp. Med. Biol. 338:1993;515-519.
25. Ercikan-Abali E. A., Waltham M. C., Dicker A. P., Schweitzer B. I., Gritsman H., Banerjee D., Bertino J. R. Variants of human dihydrofolate reductase with substitutions at leucine-22: Effect on catalytic and inhibitor binding properties. Mol. Pharmacol. 49:1996;430-437.
26. Field H. J., Wildy P. The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J. Hyg. (Lond.). 81:1978;267-277.
27. Gilbert K. M., Weigle W. O. Th1 cell anergy and blockade in G1a phase of the cell cycle. J. Immunol. 151:1993;1245-1254.
28. Grill S. P., Wells R. J., Cheng Y. C. Utilization of an immunostaining technique to demonstrate heterogeneity in the content of dihydrofolate reductase in peripheral blast cells from a patient with acute lymphocytic leukemia. Cancer Res. 44:1984;1252-1256.
29. Hamel P. A., Gill R. M., Phillips R. A., Gallie B. L. Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12:1992;3431-3438.
30. Jackson R. C., Huennekens F. M. Turnover of dihydrofolate reductase in rapidly dividing cells. Arch. Biochem. Biophys. 154:1973;192-198.
31. Jacobson J. G., Ruffner K. L., Kosz-Vnenchak M., Hwang C. B., Wobbe K. K., Knipe D. M., Coen D. M. Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia. J. Virol. 67:1993;6903-6908.
32. Johansson M., Brismar S., Karlsson A. Human deoxycytidine kinase is located in the cell nucleus. Proc. Natl. Acad. Sci. USA. 94:1997;11941-11945.
33. Kaufman R. J., Bertino J. R., Schimke R. T. Quantitation of dihydrofolate reductase in individual parental and methotrexate-resistant murine cells: Use of a fluorescence activated cell sorter. J. Biol. Chem. 253:1978;5852-5860.
34. Kedes D. H., Ganem D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs: Implications for potential therapy. J. Clin. Invest. 99:1997;2082-2086.
35. Klatzmann D., Valery C. A., Bensimon G., Marro B., Boyer O., Mokhtari K., Diquet B., Salzmann J. L., Philippon J. A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma: Study Group on Gene Therapy for Glioblastoma. Hum. Gene Ther. 9:1998;2595-2604.
36. Kucera R., Paulus H. Localization of the deoxyribonucleotide biosynthetic enzymes ribonucleotide reductase and thymidylate synthase in mouse L cells. Exp. Cell Res. 167:1986;417-428.
37. Leeds J. M., Slabaugh M. B., Mathews C. K. DNA precursor pools and ribonucleotide reductase activity: distribution between the nucleus and cytoplasm of mammalian cells. Mol. Cell. Biol. 5:1985;3443-3450.
38. Lin S. F., Sun R., Heston L., Gradoville L., Shedd D., Haglund K., Rigsby M., Miller G. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J. Virol. 71:1997;3069-3076.
39. Luo R. X., Postigo A. A., Dean D. C. Rb interacts with histone deacetylase to repress transcription. Cell. 92:1998;463-473.
40. Margosiak S. A., Appleman J. R., Santi D. V., Blakley R. L. Dihydrofolate reductase from the pathogenic fungus Pneumocystis carinii: Catalytic properties and interaction with antifolates. Arch. Biochem. Biophys. 305:1993;499-508.
41. Medveczky M. M., Horvath E., Lund T., Medveczky P. G. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS. 11:1997;1327-1332.
42. Miller G., Heston L., Grogan E., Gradoville L., Rigsby M., Sun R., Shedd D., Kushnaryov V. M., Grossberg S., Chang Y. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol. 71:1997;314-324.
43. Nicholas J., Ruvolo V., Zong J., Ciufo D., Guo H. G., Reitz M. S., Hayward G. S. A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J. Virol. 71:1997;1963-1974.
44. Nutter L. M., Grill S. P., Cheng Y. C. The sources of thymidine nucleotides for virus DNA synthesis in herpes simplex virus type 2-infected cells. J. Biol. Chem. 260:1985;13272-13275.
45. Osborn M. J., Huennekens F. M. Enzymatic reduction of dihydrofolic acid. Biochemistry. 233:1958;969-974.
46. Prem veer Reddy G., Pardee A. B. Multienzyme complex for metabolic channeling in mammalian DNA replication. Proc. Natl. Acad. Sci. USA. 77:1980;3312-3316.
47. Prendergast N. J., Delcamp T. J., Smith P. L., Freisheim J. H. Expression and site-directed mutagenesis of human dihydrofolate reductase. Biochemistry. 27:1988;3664-3671.
48. Prichard M. N., Shipman C. Jr. Ribonucleotide reductase: An important enzyme in the replication of herpes simplex virus type 1 and a target for antiviral chemotherapy. Chemotherapy. 41:1995;384-395.
49. Russo J. J., Bohenzky R. A., Chien M. C., Chen J., Yan M., Maddalena D., Parry J. P., Peruzzi D., Edelman I. S., Chang Y., Moore P. S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA. 93:1996;14862-14867.
50. Samsonoff W. A., Reston J., McKee M., O'Connor B., Galivan J., Maley G., Maley F. Intracellular location of thymidylate synthase and its state of phosphorylation. J. Biol. Chem. 272:1997;13281-13285.
51. Schweitzer B. I., Srimatkandada S., Gritsman H., Sheridan R., Venkataraghavan R., Bertino J. R. Probing the role of two hydrophobic active site residues in the human dihydrofolate reductase by site-directed mutagenesis. J. Biol. Chem. 264:1989;20786-20795.
52. Searles R. P., Bergquam E. P., Axthelm M. K., Wong S. W. Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 73:1999;3040-3053.
53. Slansky J. E., Li Y., Kaelin W. G., Farnham P. J. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell. Biol. 13:1993;1610-1618.
54. Spector T., Lobe D. C., Ellis M. N., Blumenkopf T. A., Szczech G. M. Inactivators of herpes simplex virus ribonucleotide reductase: Hematological profiles and in vivo potentiation of the antiviral activity of acyclovir. Antimicrob. Agents Chemother. 36:1992;934-937.
55. Sun R., Lin S. F., Staskus K., Gradoville L., Grogan E., Haase A., Miller G. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 73:1999;2232-2242.
56. Tenser R. B., Hay K. A., Edris W. A. Latency-associated transcript but not reactivatable virus is present in sensory ganglion neurons after inoculation of thymidine kinase-negative mutants of herpes simplex virus type 1. J. Virol. 63:1989;2861-2865.
57. Tsay J. T., Appleman J. R., Beard W. A., Prendergast N. J., Delcamp T. J., Freisheim J. H., Blakley R. L. Kinetic investigation of the functional role of phenylalanine-31 of recombinant human dihydrofolate reductase. Biochemistry. 29:1990;6428-6436.
58. Wang Y., Mathews C. K. Analysis of T4 bacteriophage deletion mutants that lack td and frd genes. J. Virol. 63:1989;4736-4743.
59. Weintraub S. J., Chow K. N., Luo R. X., Zhang S. H., He S., Dean D. C. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature. 375:1995;812-815.
60. Werkheiser W. Specific binding of 4-amino folic acid analogues by folic acid reductase. J. Biol. Chem. 236:1960;888-893.
61. Wheeler L. J., Ray N. B., Ungermann C., Hendricks S. P., Bernard M. A., Hanson E. S., Mathews C. K. T4 phage gene 32 protein as a candidate organizing factor for the deoxyribonucleoside triphosphate synthetase complex. J. Biol. Chem. 271:1996;11156-11162.